Gluten Intolerance Treatment Market size was over USD 842.52 million in 2024 and is projected to reach USD 4.52 billion by 2037, witnessing around 13.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of gluten intolerance treatment is assessed at USD 1.03 billion.
The market growth is backed by the growing research on how to reverse gluten intolerance. This is resulting in the rise in clinical trials and the development of workable gluten intolerance treatments.
The rising incidence of gluten-related disorders (GRDs) and the rise in their global prevalence is predicted in about 5% of the population. The ingestion of the gluten proteins present in wheat, barley, and rye is considered the main cause of GRDs. GRDs refer to a group of conditions that are heterogeneous, reflecting their autoimmune, allergic, and non-autoimmune-allergic etiology. The increasing adoption of gluten intolerance treatment by people suffering from GRDs is will positively impact the growth of the market.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
13.8% |
|
Base Year Market Size (2024) |
USD 842.52 million |
|
Forecast Year Market Size (2037) |
USD 4.52 billion |
|
Regional Scope |
|
Gluten-Related Disorders {Celiac Disease (CD), Dermatitis Herpetiformis (DH), Gluten Ataxia (GA), Wheat Allergy (WA), Non-Celiac Gluten Sensitivity (NCGS)}
The celiac disease segment in the gluten intolerance treatment market is set to hold the largest revenue share of 40% by 2037. Celiac disease is one of the most common examples of several types of gluten intolerance and people with celiac disease also use gluten intolerance treatment as they have high levels of certain antibodies in their blood, which are substances that fight gluten.
The increasing prevalence of celiac disease which is a serious autoimmune disease where the ingestion of gluten leads to damage in the small intestine is also considered to propel the segment growth. According to a prediction, celiac disease affects 1 in 100 people worldwide, but only around 30% are properly diagnosed. Moreover, as gluten sensitivity and celiac disease cause a lot of the same symptoms, the increase in the disease share is expected to provide numerous growth opportunities to the market players.
Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Specialty Pharmacy, Online Pharmacy)
Gluten intolerance treatment market from the retail pharmacy segment is poised to register significant growth rate through 2036, owing to the rise in demand for over-the-counter (OTC) medications. Going forward most gluten-tolerance or allergy drugs need a prescription for an over-the-counter allergy drug which is predicted to be the major growth factor of the segment.
Our in-depth analysis of the market includes the following segments:
|
Type |
|
|
Gluten-Related Disorders |
|
|
Distribution Channel |
|
European Market Forecast
Europe industry is predicted to dominate majority revenue share of 34% by 2037, due to increasing review of the broad spectrum of gluten-related disorders, with focused clinical investigations, diagnostic criteria, and therapeutic approaches for different conditions causing gluten intolerance.The increasing review of the broad spectrum of gluten-related disorders, with focused clinical investigations, diagnostic criteria, and therapeutic approaches for different conditions causing gluten intolerance will drive its treatment market in the region.
The prevalence of celiac disease, primarily in Northern European, specifically, in countries like Finland that have a relatively high rate of this condition is gradually leading the region towards improved methods of diagnosis and recognition and treatment of such conditions, bolstering the regional market expansion. Nearly 2.5% of all adults between the ages of 30 and 64 have been diagnosed with celiac disease in Finland.
APAC Market Statistics
The Asia Pacific region is projected to account for 25% of the overall gluten intolerance treatment market share by 2037. The growing concern about gluten intolerance that is on the rise among Asians, especially among the population of China and India is anticipated to boost the market demand in the region.
China and India are the most populous countries in the world and the increasing evolution of modern farming practices for wheat cultivation, with advancements in food processing, has resulted in higher gluten content in wheat which is considered a major factor that will lead to the higher incidence of gluten intolerance in the region.
Author Credits: Radhika Pawar
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?